The Market Reports

Synopsis
The global market for Eyedrops was estimated to be worth US$ 16490 million in 2024 and is forecast to a readjusted size of US$ 23600 million by 2031 with a CAGR of 5.4% during the forecast period 2025-2031.
This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Eyedrops cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Eye drops are liquid preparations that act directly on the eyes, mainly used to treat, relieve or prevent various eye diseases and discomfort symptoms. By dripping into the conjunctival sac, the drug ingredients can quickly act on the surface of the eyeball or the tissue inside the eye. It has the characteristics of rapid onset, high local concentration and small systemic side effects. According to the purpose, it can be divided into fatigue relief type, antibacterial and anti-inflammatory type, artificial tear type, anti-allergic type, intraocular pressure lowering type, etc. In sales statistics, "piece" is the basic unit, which refers to the smallest retail package, and one piece contains a single bottle or multiple eye drops.
The global eye drops market is driven by three main factors: the aging population and the popularity of electronic products have led to a high incidence of eye diseases such as dry eye; innovative drug research and development has promoted the expansion of treatment areas; and consumption upgrades in emerging markets. The development of eye drops faces three major restrictions: stricter regulatory policies in various countries, especially restrictions on products containing preservatives; foreign giants monopolize the high-end market; and competition in the mid- and low-end markets is highly homogenized. The Chinese market is growing the fastest, but local companies need to break through technical and brand barriers to compete with foreign capital.
This report aims to provide a comprehensive presentation of the global market for Eyedrops, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Eyedrops by region & country, by Type, and by Application.
The Eyedrops market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Eyedrops.
Market Segmentation
By Company
AbbVie
Alcon
Bausch and Lomb
Santen
Zhenshiming
Yuanda Pharmaceutical
Freda Pharmaceutical
Renhe Group
Shapuaisi
Kanghong Pharmaceutical
Essen Biopharma
Zhongsheng Pharmaceutical
Segment by Type
Fatigue Relief Type
Antibacterial and Anti-inflammatory Type
Artificial Tears Type
Anti-allergic Type
IOP Lowering Type
Others
Segment by Application
Pharmacies
Hospitals and Clinics
Online Sales
Optics Stores
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Eyedrops manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Eyedrops in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Eyedrops in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Index